MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Accounts payable$423K (359.78%↑ Y/Y)Other assets-$386K (55.73%↑ Y/Y)Amortization of right of useassets$234K Prepaid and othercurrent assets-$95K (-149.48%↓ Y/Y)Depreciation andamortization$95K (-50.26%↓ Y/Y)Write-off of patents$13K Share-based compensationcosts$4K (-83.33%↓ Y/Y)Total adjustments$615K (-47.48%↓ Y/Y)Net loss fromcontinuing operations$164K (280.22%↑ Y/Y)Canceled cashflow$635K Net cash provided bycontinuing operating...$779K (-27.87%↓ Y/Y)Accrued expenses andother current...-$363K (-532.14%↓ Y/Y)Lease liabilities-$271K (39.10%↑ Y/Y)Other non-currentliabilities-$1K (-101.15%↓ Y/Y)Net increase in cashand cash...$770K (-23.76%↓ Y/Y)Canceled cashflow$17K Net cash used indiscontinued operations-$17K Net cash used inoperating activities-$9K (87.14%↑ Y/Y)something is missing-$8K
Cash Flow

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD, Inc. (TXMD)

source: myfinsight.com